InvestorsHub Logo
Followers 0
Posts 79
Boards Moderated 0
Alias Born 06/29/2016

Re: someconcerns post# 2211

Sunday, 07/31/2016 9:41:44 PM

Sunday, July 31, 2016 9:41:44 PM

Post# of 3088
It does make sense for OPK to acquire CDXC. This is in particular if Niagen does go on to become a blockbuster and a widely-used tool to improve health and reduce sickness. In that extreme case, a lot of pharma businesses (possibly including OPK's) are getting crippled. Not my base case just yet though.

But I actually think CDXC a perfect fit for DSM. It intrigues me that DSM is a strategic investor in CDXC, has someone sitting in CDXC's Scientific Advisory Board, and also has a former executive as CDXC's VP of Sales & Marketing. And CDXC's business fits naturally in a DSM division already!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News